EXACT Therapeutics AS (OSL:EXTX)

Norway flag Norway · Delayed Price · Currency is NOK
2.580
-0.280 (-9.79%)
At close: Jun 18, 2025
-65.14%
Market Cap 163.22M
Revenue (ttm) n/a
Net Income (ttm) -52.33M
Shares Out 63.26M
EPS (ttm) -1.51
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 46,668
Average Volume 39,555
Open 2.580
Previous Close 2.860
Day's Range 2.580 - 2.780
52-Week Range 2.360 - 7.950
Beta 0.19
RSI 43.25
Earnings Date Sep 10, 2025

About EXACT Therapeutics AS

EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology and brain diseases. The company’s ACT platform is under Phase I clinical trial for treatment of liver metastases; and pre-clinical studies for pancreatic, glioblastoma, an... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Employees 12
Stock Exchange Oslo Børs
Ticker Symbol EXTX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.